Aeolus Pharma Balance Sheet - Quarterly (OTCMKTS:AOLS)

Add to My Stocks
$0 $0 (0%) AOLS stock closing price Sep 18, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Aeolus Pharma, and helps in stock analysis. As in our Aeolus Pharma stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. A company releases its balance sheet every quarter along with its quarterly results. The Aeolus Pharma balance sheet for 2017 Q3 shows total assets of $-. The company has a asset turnover ratio of . Also see: Aeolus Pharma revenue and Aeolus Pharma operating cash flow for the same quarter.

View and download Aeolus Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Oct - Sep2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Cash--1.89M3.15M3.75M4.5M5.44M
Marketable Securities-------
Receivables-----1.36M-
Inventory-------
Raw Materials-------
Work In Progress-------
Finished Goods-------
Notes Receivable-------
Other Current Assets-------
Total Current Assets
-1.73M2.61M4.13M4.84M6.22M6.38M
Property Plant & Equipment-------
Accumulated Depreciation-------
Net Property Plant & Equipment
-------
Investment & Advances-------
Other Non-Current Assets-------
Deferred Charges-------
Intangibles-------
Deposits & Other Assets-------
Total Assets
-1.76M2.64M4.16M4.87M6.26M6.41M
Notes Payable-------
Accounts Payable-----1.03M-
Current Portion Long-Term Debt-------
Current Portion Capital Leases-------
Accrued Expenses-------
Income Taxes Payable-------
Other Current Liabilities-------
Total Current Liabilities
-----1.23M-
Mortgages-------
Deferred Taxes/Income-------
Convertible Debt-------
Long-Term Debt-------
Non-Current Capital Leases-------
Other Long-Term Liabilities-------
Total Liabilities
-----1.23M-
Minority Interest-------
Preferred Stock-------
Common Stock Net1.52M1.52M1.52M1.52M1.52M1.51M1.51M
Capital Surplus191.94M191.91M191.89M191.86M191.83M191.79M191.76M
Retained Earnings-193.25M-192.31M-191.27M-190.18M-189.16M-188.29M-187.66M
Treasury Stock-------
Other Liabilities-------
Shareholders Equity-1.12M2.13M3.19M4.18M5.02M5.61M
Total Liabilities & Shareholders Equity-1.76M2.64M4.16M4.87M6.26M6.41M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Apart from balance sheet items, an investor would do well to keep track of the Aeolus Pharma stock price by looking at Aeolus Pharma historical stock prices. One can compare PE with industry average by looking at the Aeolus Pharma PE ratio chart. The common balance sheet items are:

  • Assets: An asset is a resource that a corporation like Aeolus Pharma owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for AOLS stock as of 2017 Q3 is $-. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Aeolus Pharma is $-. Shareholders equity comes under liabilities as it is money the company owes the holders of AOLS stock.

Aeolus Pharma Balance Sheet - Key Ratios

Quarterly Balance Sheets For Aeolus Pharmaceuticals, Inc. Peers

Cleveland BioLabs balance sheet, Respirerx Pharma balance sheet, Titan Pharma balance sheet